.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Teva
UBS
Express Scripts
Fuji
Federal Trade Commission
Queensland Health
Baxter
Dow
Colorcon

Generated: June 23, 2017

DrugPatentWatch Database Preview

Claims for Patent: 4,761,418

« Back to Dashboard

Claims for Patent: 4,761,418

Title: Novel compounds
Abstract:Neuromuscular blocking agents of formula (1) which are useful as skeletal muscle relaxants during surgery are disclosed. ##STR1## and X is an anion, preferably pharmaceutically acceptable.
Inventor(s): Swaringen, Jr.; Roy A. (Durham, NC), El-Sayad; Hassan A. (Nasr City, EG), Yeowell; David A. (Chapel Hill, NC), Savarese; John J. (Boxford, MA)
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC) General Hospital Corporation (Boston, MA)
Application Number:06/756,025
Patent Claims: 1. 2,2'[( E)-4-Octenedioylbis(oxytrimethylene)]bis[(trans)-1,2,3,4-tetrahydro-6,7-dim ethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium] cation in association with a pharmaceutically acceptable anion.

2. 2,2'-[(E)-4-Octenedioylbis(oxytrimethylene)]bis[(tr ans)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)is oquinolinium]dichloride.

3. (+-)trans,trans-2,2'- (Z)-4-Octenedioylbis(oxytrimethylene))bis-(1,2,3,4-tetrahydro-6,7-dimethoxy -2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium cation in association with a pharmaceutically acceptable anion.

4. (+-)trans,trans-2,2'-(Z)-4-Octenedioylb is(oxytrimethylene))bis-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-(3,4,5 -trimethoxybenzyl)isoquinolinium dichloride.

5. (E)-(1R,1'R)-2,2'-[4-Octenedioylbis(oxytr imethylene)]bis[1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-(3,4,5-trimetho xybenzyl)isoquinolinium] cation in association with a pharmaceutically acceptable anion.

6. (E)-(1R,1'R)-2, 2'-[4-Octenedioylbis(oxytrimethylene)]bis[1,2,4,3-tetrahydro-6,7-dimethoxy- 2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium]dichloride.

7. (E)-(1R,1'R,2R,2'R)-2,2'-[4-Octenedioylbis(oxytrimethylene )]bis[1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)i soquinolinium]cation in association with a pharmaceutically acceptable anion.

8. (E)- (1R,1'R,2R,2'R)-2,2'-[4-Octenedioylbis(oxytrimethylene)]bis[1,2,3,4-tetrahy dro-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium]dichlor ide.

9. ( E)-(1R,1'R,2R,2'S)-2,2'-[4-Octenedioylbis(oxytrimethylene)]bis[1,2,3,4-tetr ahydro-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium] cation in association with a pharmaceutically acceptable anion.

10. (E)-(1R,1'R,2R,2'S)-2,2'-[4-Octenedioylbis(oxytrimethylene)] bis[1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)iso quinolinium]chloride.

11. (E)-(1R,1'R,2S,2' S)-2,2'-[4-Octenedioylbis(oxytrimethylene)]bis[1,2,3,4-tetrahydro-6,7-dimet hoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium] dication in association with a pharmaceutically acceptable anion.

12. (E)-(1R,1'R,2S,2'S)-2,2'-[4-Octenedioylbis(oxytrim ethylene)]bis[1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxy benzyl)isoquinolinium]dichloride.

13. A method for producing muscle relaxation in a mammal which comprises parenterally administering to a mammal an effective muscle relaxant amount of the compound of claim 1, 3 or 5.

14. A sterile pharmaceutical composition comprising one or more of the compounds of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 in an effective muscle relaxant amount and a pharmaceutically acceptable solvent therefor.

15. A method for producing muscle relaxation in a mammal which comprises parenterally administering to a mammal an effective muscle relaxant amount of one or more of the compounds of claims 9, 10, 11 or 12.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Medtronic
Dow
Teva
Accenture
McKinsey
Fish and Richardson
Healthtrust
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot